Abstracts tagged "Pregnancy and vasculitis"

Abstract Number: 1523 • 2012 ACR/ARHP Annual Meeting
Systemic Vasculitis and Pregnancy: a Multicenter Study On Maternal and Neonatal Outcome of 43 Prospectively Followed Pregnancies
Micaela Fredi¹, Maria Grazia Lazzaroni¹, Chiari Tani², Véronique Ramoni³, Maria Gerosa⁴, Flora Inverardi⁵, Laura Andreoli¹, Laura Trespidi⁶, Mario Motta⁷, Andrea Lojacono⁸, Renato Sinico⁹, Antonio Brucato¹⁰, Roberto Caporali¹¹, Pier Luigi Meroni¹², Carlomaurizio Montecucco¹³, Marta Mosca¹⁴ and Angela Tincani¹, ¹Rheumatology Unit, University of Brescia, Brescia, Italy, ²University of Pisa, Rheumatology Unit, Pisa, Italy, ³Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ⁴Division of Rheumatology, Gaetano Pini Institute, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, ⁵Rheumatology, Division of Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ⁶Department of Obstetrics and Gynaecology, Fondazione Policlinico, Mangiagalli e Regina Elena,, Milan, ⁷Neonathology and NICU, Spedali Civili, Brescia, Italy, ⁸Obstetric and Gynecology of Brescia, Brescia, Italy, ⁹Clinical Immunology Unit and Renal Unit, Department of Medicine, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milan, Italy, ¹⁰Internal Medicine, USC Internal Medicine, Ospedali Riuniti, Bergamo, Italy, ¹¹Division of Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ¹²Division of Rheumatology, Istituto Ortopedico Gaetano Pini, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, ¹³Division of Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ¹⁴I, Rheumatology Unit, Internal Medicine, University of Pisa, Pisa, Italy
Background/Purpose: Systemic Vasculitis (SV) are rare diseases that may affect females during childbearing age. Quite a few data are available in literature, and mostly from…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].